Xiaowei Wu

Xiaowei Wu

Auto-generated profile, based on publicly available information

Xiaowei Wu

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
XWXiaowei Wu
Xiaowei Wu
QLQingyu Luo
Qingyu Luo
ZLZhihua Liu
Zhihua Liu
MCL1 is an important antiapoptotic member of the BCL-2 family that is distinguishable from other family members based on its relatively short half-life. Emerging studies have revealed the crucial role of MCL1 in the chemoresistance of cancer cells. The antiapoptotic function of MCL1 makes it a popular therapeutic target, although specific inhibitors have begun to emerge only recently. Notably, emerging studies have reported that several E3 ligases and deubiquitinases modulate MCL1 stability, providing an alternate means of targeting MCL1 activity. In addition, the emergence and development of proteolysis-targeting chimeras, the function of which is based on ubiquitination-mediated degradation, has shown great potential. In this review, we provide an overview of the studies investigating the ubiquitination and deubiquitination of MCL1, summarize the latest evidence regarding the development of therapeutic strategies targeting MCL1 in cancer treatment, and discuss the promising future of targeting MCL1 via the ubiquitin–proteasome system in clinical practice.

4 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XWXiaowei Wu
Xiaowei Wu
QLQingyu Luo
Qingyu Luo
PZPengfei Zhao
Pengfei Zhao
WCWan Chang
Wan Chang
YWYating Wang
Yating Wang
ZLZhihua Liu
Zhihua Liu
Significance: Ovarian cancer is the leading cause of death among gynecological malignancies and has a poor prognosis characterized by resistance to chemotherapy. MCL1 has been found to play an essential role in chemoresistance and could be a promising therapeutic target. However, designing specific inhibitors targeting MCL1 remains challenging. Here, we found that deubiquitinating enzyme 3 (DUB3) stabilizes MCL1 via deubiquitination. We identified that O6-methylguanine-DNA methyltransferase (MGMT) is a key activator of DUB3 transcription and that the MGMT inhibitor PaTrin-2 effectively suppresses ovarian cancer cells with elevated MGMT-DUB3-MCL1 expression. We further showed that histone deacetylase (HDAC) inhibitors could significantly activate MGMT/DUB3 expression to sensitize ovarian cancer cells to PaTrin-2, providing an ideal therapeutic option involving the combined treatment of HDACis and PaTrin-2 in ovarian cancer.

8 February 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
QLQingyu Luo
Qingyu Luo
XWXiaowei Wu
Xiaowei Wu
PZPengfei Zhao
Pengfei Zhao
YNYabing Nan
Yabing Nan
WCWan Chang
Wan Chang
ZLZhihua Liu
Zhihua Liu
Apoptosis‐inducing factor (AIF) plays a dual role in regulating cell survival and apoptosis, acting as a prosurvival factor in mitochondria via its NADH oxidoreductase activity and activating the caspase‐independent apoptotic pathway (i.e., parthanatos) after nuclear translocation. However, whether one factor conjunctively controls the separated functions of AIF is not clear. Here, it is shown that OTU deubiquitinase 1 (OTUD1) acts as a link between the two functions of AIF via deubiquitination events. Deubiquitination of AIF at K244 disrupts the normal mitochondrial structure and compromises oxidative phosphorylation, and deubiquitination of AIF at K255 enhances its DNA‐binding ability to promote parthanatos. Moreover, OTUD1 stabilizes DDB1 and CUL4 associated factor 10 (DCAF10) and recruits the cullin 4A (CUL4A)‐damage specific DNA binding protein 1 (DDB1) complex to promote myeloid cell leukemia sequence 1 (MCL1) degradation, thereby activating caspase‐dependent apoptotic signaling. Collectively, these results reveal the central role of OTUD1 in activating both caspase‐independent and caspase‐dependent apoptotic signaling and propose decreased OTUD1 expression as a key event promoting chemoresistance in esophageal squamous cell carcinoma.

1 May 2019 in Cell Death & Differentiation
Verified
Journal Article
Closed access
XWXiaowei Wu
Xiaowei Wu
QLQingyu Luo
Qingyu Luo
PZPengfei Zhao
Pengfei Zhao
WCWan Chang
Wan Chang
YWYating Wang
Yating Wang
ZLZhihua Liu
Zhihua Liu

15 February 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TTTian Tian
Tian Tian
XLXukun Li
Xukun Li
ZHZhen Hua
Zhen Hua
JMJianlin Ma
Jianlin Ma
XWXiaowei Wu
Xiaowei Wu
ZCZhumei Cui
Zhumei Cui
S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial–mesenchymal transition

8 May 2024 in Nature
Verified
Journal Article
Closed access
PDF file
QLQingyu Luo
Qingyu Luo
EREvangeline G. Raulston
Evangeline G. Raulston
MPMiguel A. Prado
Miguel A. Prado
XWXiaowei Wu
Xiaowei Wu
KGKira Gritsman
Kira Gritsman
ALAndrew A Lane
Andrew A Lane